HRP20030833B1 - Liquid pharmaceutical composition - Google Patents

Liquid pharmaceutical composition

Info

Publication number
HRP20030833B1
HRP20030833B1 HR20030833A HRP20030833A HRP20030833B1 HR P20030833 B1 HRP20030833 B1 HR P20030833B1 HR 20030833 A HR20030833 A HR 20030833A HR P20030833 A HRP20030833 A HR P20030833A HR P20030833 B1 HRP20030833 B1 HR P20030833B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
liquid pharmaceutical
composition
polyhydric alcohols
volume
Prior art date
Application number
HR20030833A
Other languages
English (en)
Croatian (hr)
Inventor
Mahesh Kulkarni Neema
Schneider Michael
Bernard Silbering Steven
Richard Meyer-Wonnay Hans
Sanii-Yahyai Nahid
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030833(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of HRP20030833A2 publication Critical patent/HRP20030833A2/hr
Publication of HRP20030833B1 publication Critical patent/HRP20030833B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
HR20030833A 2001-05-25 2003-10-14 Liquid pharmaceutical composition HRP20030833B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29383201P 2001-05-25 2001-05-25
US34373301P 2001-10-25 2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en) 2001-05-25 2002-04-29 Liquid pharmaceutical composition

Publications (2)

Publication Number Publication Date
HRP20030833A2 HRP20030833A2 (en) 2004-08-31
HRP20030833B1 true HRP20030833B1 (en) 2007-04-30

Family

ID=26968180

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030833A HRP20030833B1 (en) 2001-05-25 2003-10-14 Liquid pharmaceutical composition

Country Status (44)

Country Link
US (2) US20020198261A1 (no)
EP (1) EP1395242B1 (no)
JP (1) JP2004534764A (no)
KR (1) KR100582963B1 (no)
CN (1) CN100346779C (no)
AP (1) AP1815A (no)
AR (1) AR033922A1 (no)
AT (1) ATE334656T1 (no)
AU (1) AU2002258026B2 (no)
BG (1) BG108376A (no)
BR (1) BR0209973A (no)
CA (1) CA2446574C (no)
CR (1) CR7150A (no)
CY (1) CY1105147T1 (no)
CZ (1) CZ299755B6 (no)
DE (1) DE60213592T2 (no)
DK (1) DK1395242T3 (no)
DO (1) DOP2002000403A (no)
EA (1) EA008087B1 (no)
EE (1) EE200300587A (no)
EG (1) EG24078A (no)
ES (1) ES2265040T3 (no)
GE (1) GEP20053620B (no)
HK (1) HK1062646A1 (no)
HR (1) HRP20030833B1 (no)
HU (1) HUP0401366A2 (no)
IL (1) IL158359A0 (no)
IS (1) IS2428B (no)
MA (1) MA27026A1 (no)
MX (1) MXPA03009392A (no)
MY (1) MY128615A (no)
NO (1) NO20035200L (no)
NZ (1) NZ529173A (no)
OA (1) OA12604A (no)
PA (1) PA8545901A1 (no)
PE (1) PE20030087A1 (no)
PL (1) PL366384A1 (no)
PT (1) PT1395242E (no)
RS (1) RS87203A (no)
SI (1) SI1395242T1 (no)
SK (1) SK286227B6 (no)
SV (1) SV2003001053A (no)
WO (1) WO2002094220A1 (no)
ZA (1) ZA200308393B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE41920E1 (en) 1996-07-24 2010-11-09 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2494811A1 (en) * 2002-08-15 2004-02-26 Pfizer Inc. Therapeutic use of fused bicyclic or tricyclic amino acids
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
CA2505788A1 (en) * 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
KR20050084445A (ko) * 2002-12-20 2005-08-26 다이노젠 파마세우티컬스, 인코포레이티드 α₂δ 서브유닛 칼슘 채널 모듈레이터를 이용한 무통증방광 질환의 치료방법
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
MXPA06002789A (es) * 2003-09-12 2006-06-14 Pfizer Combinaciones que comprenden ligandos alfa-2-delta.
ATE526988T1 (de) * 2003-10-08 2011-10-15 Mallinckrodt Llc Methylphenidat-lösung und relevante verabreichungs- und herstellungsverfahren
US20050090548A1 (en) * 2003-10-23 2005-04-28 Medtronic, Inc. Intrathecal gabapentin for treatment of epilepsy
US20050090549A1 (en) * 2003-10-23 2005-04-28 Medtronic, Inc. Intrathecal gabapentin for treatment of pain
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
DE102004015752B4 (de) * 2004-03-31 2007-04-05 Christian-Albrechts-Universität Zu Kiel Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
EP1806133A1 (en) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Method for modifying the ambience, and spray liquid and sprayer used in the method
US20100168070A1 (en) * 2005-08-11 2010-07-01 Niklas Heine Compounds for the treatment of alzheimer's disease
US20100144681A1 (en) * 2005-08-11 2010-06-10 Klaus Fuchs Compounds for the treatment of alzheimer's disease
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
EP2116618A1 (en) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) * 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) * 2015-05-31 2015-09-30 黑龙江佰彤儿童药物研究有限公司 一种治疗儿童癫痫药物口服乳剂及其制备方法
US11918684B2 (en) 2017-03-13 2024-03-05 Liqmeds Worldwide Limited Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PREPARATION METHOD THEREOF
WO2019186515A1 (en) * 2018-03-30 2019-10-03 Ftf Pharma Private Limited Liquid pharmaceutical compositions of antiepileptic drugs
EP3836898A2 (en) 2018-08-18 2021-06-23 FTF Pharma Private Limited Pharmaceutical suspension for oral dosage
US20230255885A1 (en) * 2018-08-18 2023-08-17 Ftf Pharma Private Limited Chemotherapeutic pharmaceutical suspension for oral dosage
EP3946260A1 (en) 2019-03-26 2022-02-09 Orion Corporation Pregabalin formulations and use thereof
JPWO2022168968A1 (no) * 2021-02-05 2022-08-11
CA3230309A1 (en) * 2021-08-31 2023-03-09 Jr. Samuel A. Testino Stable gabapentin powder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
HU228771B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
AP2001002360A0 (en) * 2000-11-30 2001-12-31 Pfizer Prod Inc Combination of gaba agonists and sorbitol dehydrogenase inhibitors.

Also Published As

Publication number Publication date
AU2002258026B2 (en) 2007-08-02
DOP2002000403A (es) 2002-11-30
SK14112003A3 (sk) 2004-08-03
HUP0401366A2 (hu) 2004-11-29
SV2003001053A (es) 2003-03-18
CY1105147T1 (el) 2010-03-03
NO20035200D0 (no) 2003-11-24
EE200300587A (et) 2004-02-16
PL366384A1 (en) 2005-01-24
WO2002094220A1 (en) 2002-11-28
KR20040003006A (ko) 2004-01-07
KR100582963B1 (ko) 2006-05-24
AP1815A (en) 2008-01-04
CZ299755B6 (cs) 2008-11-12
PA8545901A1 (es) 2003-09-05
CZ20033066A3 (cs) 2004-08-18
IS6986A (is) 2003-10-09
EG24078A (en) 2008-05-11
CN1509165A (zh) 2004-06-30
GEP20053620B (en) 2005-09-26
BR0209973A (pt) 2004-04-06
DK1395242T3 (da) 2006-10-30
IS2428B (is) 2008-10-15
ATE334656T1 (de) 2006-08-15
CA2446574A1 (en) 2002-11-28
EP1395242A1 (en) 2004-03-10
CN100346779C (zh) 2007-11-07
EA200301152A1 (ru) 2004-04-29
SI1395242T1 (en) 2006-10-31
NZ529173A (en) 2005-07-29
DE60213592T2 (de) 2007-08-09
ZA200308393B (en) 2005-04-26
NO20035200L (no) 2003-11-24
MA27026A1 (fr) 2004-12-20
EP1395242B1 (en) 2006-08-02
AP2003002907A0 (en) 2003-12-31
DE60213592D1 (de) 2006-09-14
PE20030087A1 (es) 2003-02-14
ES2265040T3 (es) 2007-02-01
HK1062646A1 (en) 2004-11-19
HRP20030833A2 (en) 2004-08-31
US20040072904A1 (en) 2004-04-15
RS87203A (en) 2006-10-27
MXPA03009392A (es) 2004-01-29
PT1395242E (pt) 2006-11-30
AR033922A1 (es) 2004-01-07
US7256216B2 (en) 2007-08-14
JP2004534764A (ja) 2004-11-18
EA008087B1 (ru) 2007-02-27
OA12604A (en) 2006-06-08
CR7150A (es) 2004-02-23
MY128615A (en) 2007-02-28
BG108376A (bg) 2005-04-30
IL158359A0 (en) 2004-05-12
SK286227B6 (sk) 2008-05-06
CA2446574C (en) 2008-04-01
US20020198261A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
HRP20030833B1 (en) Liquid pharmaceutical composition
HN2002000154A (es) Azaindoles
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
DE60229165D1 (de) Verbindungen zur kontrollierten freigabe aktiver molekülen
DE69920017D1 (de) Neue form vom irbesartan, verfahren um diese form zu erhalten und sie enthaltende pharmazeutische zusammensetzungen
RS54573B1 (en) MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
CR8107A (es) Fungicida
MY133174A (en) Dipeptide nitriles
ME00671B (me) Nova farmaceutska smeša
RS51808B (en) PROCEDURES FOR THE APPLICATION OF AMINOPYRIDINE COMPOUNDS WITH LONG TERM RELEASE
DK1273299T3 (da) Minoxidilinindeholdende praparater
UY27329A1 (es) Champues con alcohol de behenilo
ES2193874B1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
CY1107196T1 (el) Υποκατεστημενα παραγωγα 2,4-διϋδρο-πυρρολο (3,4-β) -κινολιν-9-ονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
ATE515252T1 (de) Pseudokörpergeruchszusammensetzung
ATE359279T1 (de) Moschus-geruchsstoffe
DE60132441D1 (de) A als inhibitor der no-synthase und verwendungen
PL1553162T5 (pl) Toaletowe kostki
RS50310B (sr) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
CO5590936A2 (es) Compuesto farmaceutico que contiene sfcyr iib o sfcyr iii
DE60001366T2 (de) Orale zusammensetzung enthaltend perlit
ATE273985T1 (de) Ruthenium (ii) verbindungen in der krebsbehandlung
ATE342880T1 (de) Aliphatische verbindungen als duftstoffe mit moschuscharakter
TNSN98013A1 (fr) Derives de 5 - aroylnaphtalene a action anti-inflammatoire et analgesique, compositions pharmaceutiques les contenant, et procedes pour les utiliser et les preparer.
DE602004029459D1 (de) Verbessertes reinigungsmittel

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080402

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20090430